@article{borgcomment,
  added-at = {2014-01-07T10:00:43.000+0100},
  author = {Borg, J J and Serracino-Inglott, A and Azzopardi, L M and Schneider, C K},
  biburl = {https://www.bibsonomy.org/bibtex/2c4ee3b649c5c31a614f8d37e1edec29d/kalinke},
  editor = {Saf, Drug},
  interhash = {40717d91490f0bee7fbf580967e018d2},
  intrahash = {c4ee3b649c5c31a614f8d37e1edec29d},
  journal = {Drug Saf},
  keywords = {kalinke},
  number = 2,
  pages = {123-124},
  pubmedurl = {http://www.ncbi.nlm.nih.gov/m/pubmed/24338043/},
  timestamp = {2014-02-13T12:56:15.000+0100},
  title = {Comment On: "EU's New Pharmacovigilance Legislation: Considerations for Biosimilars"},
  volume = 37,
  year = 2014
}